Touyun Biotech Group Limited
HKEX:1332.HK
0.178 (HKD) • At close September 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -268.939 | -199.183 | -122.97 | -171.983 | -194.896 | -251.974 | -248.987 | -1,163.797 | 256.263 | 13.156 | 19.712 | 26.171 | 46.421 |
| Depreciation & Amortization
| 36.585 | 33.138 | 22.7 | 28.449 | 31.582 | 28.507 | 9.385 | 3.357 | 3.073 | 5.248 | 5.519 | 5.384 | 6.236 |
| Deferred Income Tax
| 0 | 0 | 36.34 | 58.141 | 126.918 | 74.946 | 185.045 | -0.001 | -301.486 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 2.587 | 6.859 | 16.18 | 4.261 | 15.135 | 15.87 | 10.006 | 0.001 | 51.7 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 17.024 | -19.397 | -23.034 | 35.321 | -197.912 | -2.026 | -1.835 | 268.244 | -468.805 | 9.938 | -10.076 | -12.172 | -0.634 |
| Accounts Receivables
| 24.513 | -8.549 | -74.28 | -25.889 | -61.174 | 13.736 | -21.98 | 30.223 | -30.223 | -3.857 | -0.547 | 0 | 0 |
| Inventory
| 3.221 | -2.847 | 0.975 | 2.191 | 7.719 | -11.766 | 3.946 | 7.707 | 8.777 | 2.798 | -6.334 | 2.805 | 5.61 |
| Accounts Payables
| -10.71 | -25.601 | 34.867 | 12.15 | -9.882 | 7.311 | 21.98 | -30.223 | 30.223 | 3.857 | 0.547 | 0 | 0 |
| Other Working Capital
| 18.541 | 17.6 | 15.404 | 46.869 | -134.575 | -11.307 | 16.199 | 230.314 | -447.359 | 10.997 | -3.195 | -14.977 | -6.244 |
| Other Non Cash Items
| 255.874 | 152.211 | 16.97 | 30.463 | 14.23 | 17.559 | 5.485 | 1,118.093 | 0.316 | -0.048 | -1.235 | -3.826 | -6.844 |
| Operating Cash Flow
| -15.602 | -26.372 | -53.814 | -15.348 | -204.943 | -117.118 | -40.901 | 225.898 | -458.939 | 28.294 | 13.92 | 15.557 | 45.179 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -17.133 | -12.93 | -250.79 | -125.513 | -7.642 | -36.215 | -51.994 | -6.306 | -0.214 | -0.434 | -3.347 | -1.389 | -0.159 |
| Acquisitions Net
| 7.186 | 8.149 | 152.077 | 32.794 | 1.508 | 2.827 | -56.112 | -251.903 | 118.991 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -55 | -5.465 | -52.3 | 0 | -48.96 | -120.2 | 0 | -150 | -170.025 | -75.894 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | -8.149 | 0 | 42.12 | 10.928 | 115.952 | 0 | 16.179 | 84.849 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -53.814 | 1.149 | 3.276 | 2.731 | 200 | 8.854 | -9.65 | 150 | 35.375 | 4.559 | 0.031 | -7.452 | 0.829 |
| Investing Cash Flow
| -64.947 | -17.246 | -147.737 | -47.868 | 155.834 | -28.782 | -117.756 | -242.03 | 68.976 | -71.769 | -3.316 | -8.841 | 0.67 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -23.82 | -214.947 | -120.857 | -98.056 | -3.276 | -105.836 | -12.022 | -459.053 | -201.053 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 31.265 | 119.847 | 0 | 0 | 0 | 618.037 | 191.209 | 0 | 0 | 22.858 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.767 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -198.286 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 6.517 | 317.578 | 212.762 | 138.681 | -3.981 | -2.341 | 308.707 | 27.908 | 389.495 | 0 | -4.165 | -15.368 | -51.386 |
| Financing Cash Flow
| -33.675 | 102.631 | 123.17 | 160.472 | -7.257 | -108.177 | 296.685 | 186.892 | 389.495 | 0 | -4.165 | 7.49 | -51.386 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 1.371 | 8.887 | -3.861 | 4.727 | -0.69 | 2.935 | 4.573 | -0.885 | -0.387 | 0.007 | 0.059 | 0 | 0 |
| Net Change In Cash
| -93.605 | 67.9 | -82.242 | 101.983 | -57.056 | -251.142 | 142.601 | 169.875 | -0.855 | -43.468 | 6.498 | 14.206 | -5.537 |
| Cash At End Of Period
| 34.493 | 128.098 | 60.198 | 142.44 | 40.457 | 97.513 | 348.655 | 206.054 | 36.179 | 37.034 | 80.502 | 74.004 | 59.798 |